Literature DB >> 27868038

As"SIRT"ing the role of an epigenetic modifier in hematopoietic stem cell homeostasis.

Andrew Magimaidas1, Rachit Badolia2, Priyanka Madireddi3, Dheeraj Bhavanasi4.   

Abstract

Year:  2016        PMID: 27868038      PMCID: PMC5104590          DOI: 10.21037/sci.2016.09.09

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


× No keyword cloud information.
  19 in total

1.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

2.  SIRT1 is dispensable for function of hematopoietic stem cells in adult mice.

Authors:  Vid Leko; Barbara Varnum-Finney; Hongzhe Li; Yansong Gu; David Flowers; Cynthia Nourigat; Irwin D Bernstein; Antonio Bedalov
Journal:  Blood       Date:  2012-01-04       Impact factor: 22.113

3.  Dnmt3a is essential for hematopoietic stem cell differentiation.

Authors:  Grant A Challen; Deqiang Sun; Mira Jeong; Min Luo; Jaroslav Jelinek; Jonathan S Berg; Christoph Bock; Aparna Vasanthakumar; Hongcang Gu; Yuanxin Xi; Shoudan Liang; Yue Lu; Gretchen J Darlington; Alexander Meissner; Jean-Pierre J Issa; Lucy A Godley; Wei Li; Margaret A Goodell
Journal:  Nat Genet       Date:  2011-12-04       Impact factor: 38.330

4.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

Authors:  M Kaeberlein; M McVey; L Guarente
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

Review 5.  The multifaceted functions of sirtuins in cancer.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

6.  The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine.

Authors:  Jean-Pierre Etchegaray; Lukas Chavez; Yun Huang; Kenneth N Ross; Jiho Choi; Barbara Martinez-Pastor; Ryan M Walsh; Cesar A Sommer; Matthias Lienhard; Adrianne Gladden; Sita Kugel; Dafne M Silberman; Sridhar Ramaswamy; Gustavo Mostoslavsky; Konrad Hochedlinger; Alon Goren; Anjana Rao; Raul Mostoslavsky
Journal:  Nat Cell Biol       Date:  2015-04-27       Impact factor: 28.824

7.  SIRT3 reverses aging-associated degeneration.

Authors:  Katharine Brown; Stephanie Xie; Xiaolei Qiu; Mary Mohrin; Jiyung Shin; Yufei Liu; Dan Zhang; David T Scadden; Danica Chen
Journal:  Cell Rep       Date:  2013-01-31       Impact factor: 9.423

Review 8.  Sirtuins: critical regulators at the crossroads between cancer and aging.

Authors:  L R Saunders; E Verdin
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

9.  Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib.

Authors:  Ling Li; Lisheng Wang; Liang Li; Zhiqiang Wang; Yinwei Ho; Tinisha McDonald; Tessa L Holyoake; WenYong Chen; Ravi Bhatia
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

10.  Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways.

Authors:  Jian Huang; Michelle Nguyen-McCarty; Elizabeth O Hexner; Gwenn Danet-Desnoyers; Peter S Klein
Journal:  Nat Med       Date:  2012-11-11       Impact factor: 53.440

View more
  2 in total

Review 1.  Histone deacetylase 6 in cancer.

Authors:  Ting Li; Chao Zhang; Shafat Hassan; Xinyue Liu; Fengju Song; Kexin Chen; Wei Zhang; Jilong Yang
Journal:  J Hematol Oncol       Date:  2018-09-03       Impact factor: 17.388

2.  Loss of Egr1, a human del5q gene, accelerates BCR-ABL driven chronic myelogenous leukemia.

Authors:  Silvia Maifrede; Andrew Magimaidas; Xiaojin Sha; Kaushiki Mukherjee; Dan A Liebermann; Barbara Hoffman
Journal:  Oncotarget       Date:  2017-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.